SCHEMBL21721788

SCHEMBL21721788

CC(C)c1cnc2cc(CC(C)c3cc4ccccc4n3C)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ TERT O14746 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ ATP1A1 P05023 1/20 0.33
▸ ATP1B1 P05026 1/20 0.33
▸ ATP1A3 P13637 1/20 0.33
▸ ATP1B2 P14415 1/20 0.33
▸ ATP1A2 P50993 1/20 0.33
▸ ATP1B3 P54709 1/20 0.33
▸ FXYD2 P54710 1/20 0.33
▸ ATP1A4 Q13733 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALOX5AP P20292 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23939714 0.77 HTR2A (0.40) HTR2AHTR2CHTR2B
SCHEMBL23841158 0.77 HTR2A (0.38) PIK3CDHTR2AHTR2CHTR2BMAPT
SCHEMBL20178504 0.75 ABL1 (0.39) NPC1RAB9AHTR2AHTR2CHTR2B
SCHEMBL24758455 0.72 HTR2A (0.47) PIK3CDHTR2AHTR2CHTR2BKMT2A
SCHEMBL25728286 0.72 HTR2A (0.47) PIK3CDHTR2AHTR2CHTR2B
SCHEMBL20049318 0.71 AKR1C3 (0.43) NPC1RAB9ATP53MAPTKMT2A
SCHEMBL20469944 0.69 HTR2A (0.40) HTR2AHTR2CHTR2BKMT2AMEN1
SCHEMBL21795440 0.69 KMT2A (0.50) TERTMAPTKMT2AMEN1MCL1
SCHEMBL2607479 0.69 CYP1A2 (0.57) PIK3CDMAPTCNR2
SCHEMBL21880734 0.68 MET (0.41) NPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 — — US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C PIK3CD 1245/4885NPC1 3937/4885POLB 2724/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C PIK3CD 1245/4885NPC1 3937/4885POLB 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback